Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index
1 other identifier
observational
196
1 country
1
Brief Summary
The purpose of the study is to compare the relative contribution of systemic inflammation vs. Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2017
CompletedFirst Posted
Study publicly available on registry
February 23, 2017
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 23, 2026
April 1, 2026
10.8 years
February 16, 2017
April 20, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Presence of the metabolic syndrome
At least 3 of the following 5 risk factors must be met in order to have the metabolic syndrome: 1. Elevated waist measurement (≥102 cm for men or ≥89 cm for women) 2. Elevated triglycerides (≥150 mg/dL or use of medication) 3. Low HDL cholesterol (\<50 mg/dL for women or \<40 mg/dL for men or use of medication) 4. Elevated blood pressure (≥130 mmHg systolic or ≥ 85 mmHg diastolic or use of medication) 5. Elevated fasting blood sugar (≥100 mg/dL or use of medication) Source: https://www.nhlbi.nih.gov/health/health-topics/topics/ms
baseline
Obstructive Sleep Apnea
AHI from one night polysomnography
baseline
Markers of systemic inflammation
CRP, IL-6, TNFa
baseline
Secondary Outcomes (2)
Heart rate variability
baseline
Subjective measure of sleepiness
baseline
Eligibility Criteria
Patients with suspected OS who are being seen at the Sleep Research and Treatment Center.
You may qualify if:
- Mild to moderate OSA (5≤ AHI \<30)
- BMI ≤ 45
- Age ≥ 18
- Men \& Women
You may not qualify if:
- AHI ≥ 30
- BMI \>45
- Current use of steroids or anti-inflammatory medication
- Diagnosis of insulin dependent diabetes
- Diagnosis of autoimmune disorder
- Shiftwork
- Current use of CPAP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 16, 2017
First Posted
February 23, 2017
Study Start
March 1, 2017
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share